WallStreetZenWallStreetZen
Analyst Ranking
Bottom 6%
#4342 out of 4603 analysts
Average Return
-10.44%
Win Rate
31%17 out of 54
Risk vs Reward
Poor
Good

Elliot Wilbur's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Adma Biologics IncADMA
+146.64%$4.31$10.63
2023-08-10 -
2024-06-14
Strong Buy
Petiq IncPETQ
+144.62%$7.80$19.08
2022-10-25 -
2023-10-24
Buy
Adma Biologics IncADMA
+102.22%$1.35$2.73
2021-10-26 -
2022-10-25
Buy
Adma Biologics IncADMA
+98.11%$1.59$3.15
2021-11-11 -
2022-11-10
Strong Buy
Dermira IncDERM2
+73.63%$34.51$9.10
2017-03-16 -
2018-03-16
Sell

Elliot Wilbur Analyst Color

Get additional color on Elliot Wilbur's coverage of popular stocks

Elliot Wilbur's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Adma Biologics IncADMA
5Strong Buy$10.00-5.93%Maintains
a month ago
Sol Gel Technologies LtdSLGL
7Strong Buy$7.00+695.45%Maintains
10 months ago
Ani Pharmaceuticals IncANIP
5Buy$49.00N/AMaintains
a year ago
Organon & CoOGN
1Buy$33.00N/AInitiates Coverage On
a year ago
Perrigo Co PLCPRGO
5Buy$43.00N/AMaintains
a year ago
Petiq IncPETQ
4Buy$16.00N/AMaintains
2 years ago
Polypid LtdPYPD
3Buy$120.00N/ADowngrades
2 years ago
Covetrus IncCVET
4HoldN/AN/ADowngrades
2 years ago
Plx Pharma IncPLXPQ
3Buy$10.00N/AMaintains
2 years ago
Antares Pharma IncATRS
4HoldN/AN/ADowngrades
2 years ago
Viatris IncVTRS
3HoldN/AN/ADowngrades
2 years ago
Teva Pharmaceutical Industries LtdTEVA
2HoldN/AN/ADowngrades
3 years ago
Flexion Therapeutics IncFLXN
4HoldN/AN/ADowngrades
3 years ago
Zoetis IncZTS
4HoldN/AN/ADowngrades
3 years ago
Elanco Animal Health IncELAN
1HoldN/AN/AInitiates Coverage On
4 years ago
Dermira IncDERM2
2HoldN/AN/AUpgrades
5 years ago
Allergan PLCAGN
2Buy$198.00N/AMaintains
6 years ago
Amphastar Pharmaceuticals IncAMPH
2HoldN/AN/ADowngrades
7 years ago
Dmk Pharmaceuticals CorpDMKPQ
1Buy$490.00N/AInitiates Coverage On
7 years ago
Aerie Pharmaceuticals IncAERI
1HoldN/AN/ADowngrades
7 years ago
Lannett Co IncLCINQ
2Buy$172.00N/AMaintains
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.